A Regional Report: Respiratory Syncytial Virus Infection in 2016-17 Season
Piedimonte G, Perez MK. Respiratory Syncytial Virus Infection and Bronchiolitis. Pediatrics in Review. Dec 2014, 35 (12) 519-530; DOI: 10.1542/pir.35-12-519.
Sullender WM. Respiratory Syncytial Virus Genetic and Antigenic Diversity. Clinical Microbiology Reviews. 2000; 13(1):1-15.
Rodriguez-Fernandez R, Tapia LI, Yang CF, Torres JP, Chavez-Bueno S, Garcia C, Jaramillo LM, Moore-Clingenpeel M, Jafri HS, Peeples ME, Piedra PA, Ramilo O, Meijas A. Respiratory syncytial virus genotypes, host immune profiles and disease severity in young children hospitalized with bronchiolitis. J Infect Dis Oct 2017. DOI: 10.1093/infdis/jix543. [Epub ahead of print]
American Academy of Pediatrics, Committee on Infectious Diseases and Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics Aug 2014; 134(2):415-20. DOI: 10.1542/peds.2014-1665.
Manzoni P, Figueras-Aloy J, Simones EAF, Checchia PA, Fauroux, Bont L, Paes B, Carbonell-Estrany X. Defining incidence and associated morbidity and mortality of severe respiratory syncytial virus infection among children with chronic diseases. Infect Dis Ther Sep 2017; 6(3): 383-411. DOI: 10.1007/s40121-017-0160-3. Epub 2017 Jun 26
All articles are published under the Creative Commons Attribution-Non-Commercial License https://creativecommons.org/licenses/by-sa/2.0/